Concepts (98)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiac Surgical Procedures | 10 | 2024 | 1099 | 1.630 |
Why?
|
| Acute Kidney Injury | 8 | 2024 | 606 | 1.560 |
Why?
|
| Water-Electrolyte Imbalance | 4 | 2023 | 77 | 0.780 |
Why?
|
| Life Change Events | 1 | 2012 | 59 | 0.390 |
Why?
|
| Cyclonic Storms | 1 | 2012 | 76 | 0.370 |
Why?
|
| Disasters | 1 | 2012 | 99 | 0.360 |
Why?
|
| Hospital Rapid Response Team | 2 | 2021 | 35 | 0.350 |
Why?
|
| Diuretics | 2 | 2017 | 158 | 0.270 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2012 | 618 | 0.240 |
Why?
|
| Infant, Newborn | 9 | 2024 | 8113 | 0.240 |
Why?
|
| Risk Factors | 7 | 2022 | 9868 | 0.240 |
Why?
|
| Odds Ratio | 2 | 2021 | 1231 | 0.230 |
Why?
|
| Language Development Disorders | 1 | 2024 | 173 | 0.210 |
Why?
|
| Retrospective Studies | 12 | 2024 | 15879 | 0.210 |
Why?
|
| Logistic Models | 2 | 2021 | 1767 | 0.210 |
Why?
|
| Michigan | 1 | 2021 | 39 | 0.200 |
Why?
|
| Heart Defects, Congenital | 2 | 2024 | 1802 | 0.190 |
Why?
|
| Postoperative Period | 2 | 2023 | 330 | 0.180 |
Why?
|
| Norwood Procedures | 1 | 2022 | 100 | 0.180 |
Why?
|
| Recurrence | 1 | 2024 | 1412 | 0.180 |
Why?
|
| Chi-Square Distribution | 1 | 2021 | 580 | 0.170 |
Why?
|
| Pediatrics | 2 | 2019 | 1139 | 0.170 |
Why?
|
| Hypoplastic Left Heart Syndrome | 1 | 2022 | 251 | 0.160 |
Why?
|
| Renal Replacement Therapy | 1 | 2020 | 141 | 0.160 |
Why?
|
| Water-Electrolyte Balance | 3 | 2023 | 76 | 0.160 |
Why?
|
| Personal Autonomy | 1 | 2019 | 200 | 0.150 |
Why?
|
| Hyperglycemic Hyperosmolar Nonketotic Coma | 1 | 2017 | 9 | 0.150 |
Why?
|
| Postoperative Complications | 4 | 2023 | 2998 | 0.150 |
Why?
|
| Metolazone | 1 | 2017 | 5 | 0.150 |
Why?
|
| Diuresis | 1 | 2017 | 58 | 0.150 |
Why?
|
| Spironolactone | 1 | 2017 | 18 | 0.140 |
Why?
|
| Heart Arrest | 1 | 2021 | 341 | 0.140 |
Why?
|
| Program Evaluation | 1 | 2018 | 438 | 0.130 |
Why?
|
| Multiple Organ Failure | 1 | 2017 | 140 | 0.130 |
Why?
|
| Cardiopulmonary Bypass | 3 | 2023 | 342 | 0.130 |
Why?
|
| Humans | 19 | 2024 | 122412 | 0.130 |
Why?
|
| Potassium | 1 | 2017 | 279 | 0.130 |
Why?
|
| Thrombocytopenia | 1 | 2017 | 230 | 0.130 |
Why?
|
| Students, Medical | 1 | 2019 | 356 | 0.120 |
Why?
|
| Child | 10 | 2023 | 24108 | 0.120 |
Why?
|
| Health Personnel | 1 | 2018 | 500 | 0.110 |
Why?
|
| Heart Transplantation | 1 | 2020 | 854 | 0.110 |
Why?
|
| Multivariate Analysis | 2 | 2017 | 1403 | 0.100 |
Why?
|
| New Orleans | 1 | 2012 | 13 | 0.100 |
Why?
|
| Heart Diseases | 1 | 2017 | 479 | 0.100 |
Why?
|
| Bereavement | 1 | 2012 | 19 | 0.100 |
Why?
|
| Housing | 1 | 2012 | 59 | 0.100 |
Why?
|
| Infant | 6 | 2024 | 12347 | 0.100 |
Why?
|
| Confidence Intervals | 1 | 2012 | 275 | 0.100 |
Why?
|
| Heart-Assist Devices | 1 | 2020 | 1022 | 0.090 |
Why?
|
| Kidney | 1 | 2017 | 1345 | 0.090 |
Why?
|
| Interviews as Topic | 1 | 2012 | 365 | 0.090 |
Why?
|
| Male | 7 | 2024 | 59581 | 0.080 |
Why?
|
| Treatment Outcome | 2 | 2022 | 12035 | 0.080 |
Why?
|
| Sex Factors | 1 | 2012 | 1234 | 0.080 |
Why?
|
| Female | 6 | 2024 | 64939 | 0.070 |
Why?
|
| Furosemide | 2 | 2017 | 36 | 0.070 |
Why?
|
| Heart Failure | 1 | 2020 | 2125 | 0.070 |
Why?
|
| Health Services Accessibility | 1 | 2012 | 586 | 0.070 |
Why?
|
| Prevalence | 1 | 2012 | 2369 | 0.060 |
Why?
|
| Emergency Service, Hospital | 1 | 2012 | 1060 | 0.060 |
Why?
|
| Length of Stay | 2 | 2022 | 1272 | 0.060 |
Why?
|
| Cross-Sectional Studies | 1 | 2012 | 3305 | 0.050 |
Why?
|
| Intensive Care Units, Pediatric | 2 | 2017 | 469 | 0.050 |
Why?
|
| Catheters, Indwelling | 1 | 2023 | 156 | 0.050 |
Why?
|
| Critical Care | 2 | 2018 | 647 | 0.050 |
Why?
|
| Prostaglandins | 1 | 2021 | 48 | 0.050 |
Why?
|
| Surveys and Questionnaires | 2 | 2021 | 3611 | 0.040 |
Why?
|
| Professional Autonomy | 1 | 2019 | 27 | 0.040 |
Why?
|
| Creatinine | 1 | 2021 | 379 | 0.040 |
Why?
|
| Child Development | 1 | 2022 | 248 | 0.040 |
Why?
|
| Aged | 1 | 2017 | 18779 | 0.040 |
Why?
|
| Respiration, Artificial | 1 | 2022 | 453 | 0.040 |
Why?
|
| Monitoring, Physiologic | 1 | 2021 | 355 | 0.040 |
Why?
|
| Tertiary Care Centers | 1 | 2019 | 236 | 0.040 |
Why?
|
| Botswana | 1 | 2018 | 76 | 0.040 |
Why?
|
| Nephrology | 1 | 2020 | 144 | 0.040 |
Why?
|
| Palliative Care | 1 | 2022 | 426 | 0.040 |
Why?
|
| Intensive Care Units | 1 | 2021 | 475 | 0.040 |
Why?
|
| Acetazolamide | 1 | 2017 | 30 | 0.040 |
Why?
|
| Hypokalemia | 1 | 2017 | 41 | 0.030 |
Why?
|
| Developing Countries | 1 | 2018 | 270 | 0.030 |
Why?
|
| Hyperkalemia | 1 | 2017 | 65 | 0.030 |
Why?
|
| Linear Models | 1 | 2017 | 655 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2024 | 4984 | 0.030 |
Why?
|
| Qualitative Research | 1 | 2018 | 516 | 0.030 |
Why?
|
| Hospitals, Pediatric | 1 | 2019 | 779 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2017 | 1146 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2017 | 1678 | 0.030 |
Why?
|
| Clinical Competence | 1 | 2019 | 970 | 0.030 |
Why?
|
| Middle Aged | 1 | 2012 | 25588 | 0.030 |
Why?
|
| Adult | 1 | 2012 | 28743 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2022 | 5970 | 0.020 |
Why?
|
| Internship and Residency | 1 | 2019 | 1152 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2017 | 4648 | 0.020 |
Why?
|
| United States | 1 | 2021 | 10475 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2017 | 13837 | 0.010 |
Why?
|
| Adolescent | 1 | 2017 | 18971 | 0.010 |
Why?
|